Cough and cold have become common ailments in people for a gamut of reasons such as increased susceptibility to respiratory infections due to overwhelming upsurge in air pollution and the dynamic weather across the world which is enhancing the probability of lung infections in people. Furthermore, there is an increase in the global geriatric population, which is highly vulnerable to cough and cold. The growing number of people suffering from chronic bronchitis is also increasing, which is creating a demand influx in the [FURL=https://www.industryarc.com/PressRelease/2005/Cough-Remedies-Market-Research.html]Cough Remedies Market[/FURL].Another factor increasing opportunities for the cough remedies market growth companies is the approval of new drugs by the regulatory bodies.The companies observed substantial traction in APAC countries while the global cough remedies market size stood at $1.18 billion in 2018. The forecast period 2019-2025 will observe an increase in the cough remedies market value at a CAGR of 3.6%.According to the World Health Organization (WHO), with influenza leading to respiratory tract infections in 5-15% of the global population each year, as much as 3-5 million people are vulnerable to the subsequent repercussion in the form of cough and cold. The respiratory infections caused by influenza are also attributable to the increasing cough remedies market demand.
Browse Cough Remedies Market Report Link:
[FURL]https://www.industryarc.com/Research/Cough-Remedies-Market-Research-501866[/FURL]
APAC Cough Remedies Market & Opportunities for the Companies
APAC had the maximum cough remedies market share with 45% in 2018. While the greater APAC cough remedies market size as compared to other regions can be attributed to the active force in the growing number of people suffering from cough and other diseases with cough as a symptom which is increasing the sales of cough medicines.
Cough Remedies Market – Competitive Landscape:
The major players in the cough remedies market that are striving to capitalize on the demand influx from the consumers are Johnson & Johnson, Reckitt Benckiser Group plc, Bayer AG, GlaxoSmithKline plc., AstraZeneca, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Prestige Brands, Inc., and Procter & Gamble.
Talk to one of our sales representative about the full report by providing your details in the link below:
[FURL]https://www.industryarc.com/support.php?id=501866[/FURL]
About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.